Invivyd stock falls 13% in wake of cash crunch disclosure (NASDAQ:IVVD)

Shares of Invivyd (NASDAQ:IVVD) have been down 13% in late morning buying and selling Monday within the wake of reports that the corporate had considerations about its capability to remain in enterprise long run.

Invivyd shares just lately bought at $4.34 at round 11:25 a.m. ET after hitting a low of $3.31 earlier within the session.

Late Friday, Invivyd disclosed in an SEC submitting that it and its impartial accounting agency had substantial doubts about its capability to stay as a going concern. The corporate added that it believed it had sufficient money to fund present operations into This fall.

Invivyd modified its title from Adagio Therapeutics in September 2022.